phosphodiesterase3/beta adrenoreceptor antagonists (Artesian)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namephosphodiesterase3/beta adrenoreceptor antagonists (Artesian)
Drug Alias NameBRPM program (Artesian)BRPM program (Cardiome Pharma)phosphodiesterase 3/beta adrenoceptor antagonists (Cardiome Pharma)ATI-24214ATI-24162
ClassificationBiologics
Mechanisms of ActionPhosphodiesterase 3 inhibitorsBeta adrenergic receptors antagonists
TargetsBeta adrenergic receptorsPhosphodiesterase 3
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArtesian Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArtesian Therapeutics IncCorrevio Pharma Corp
Active IndicationsN/A
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A